Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cognizant Tech Sol (CTSH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cognizant Tech Sol GLENPOINTE CENTRE WEST 500 FRANK W. BURR BLVD. TEANECK NJ 07666 USA

www.cognizant.com P: 201-801-0233 F: 201-801-0243

Description:

Cognizant Technology Solutions Corporation operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. Its consulting and technology services include strategy consulting, business and operations consulting, technology strategy and change management, and program management consulting services; application design and development; systems integration; and application testing, consulting, and engineering services, as well as enterprise information management services. The Company also develops, licenses, implements, and supports proprietary and third-party software products for the healthcare industry. In addition, it provides outsourcing services, such as application maintenance services; IT infrastructure services; and business process services comprising clinical data management, pharmacovigilance, equity research support, commercial operations, and order management services, as well as related services, including platform-based services.

Key Statistics

Overview:

Market Capitalization, $K 43,806,284
Shares Outstanding, K 590,620
Annual Sales, $ 13,487 M
Annual Net Income, $ 1,553 M
Last Quarter Sales, $ 3,670 M
Last Quarter Net Income, $ 470,000 K
36-Month Beta 1.12
% of Insider Shareholders 1.08%
% of Institutional Shareholders 87.56%

Growth:

1-Year Total Return 47.34%
3-Year Total Return 64.46%
5-Year Total Return 122.30%
5-Year Revenue Growth 120.33%
5-Year Earnings Growth 108.39%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.93 on 08/03/17
Next Earnings Date 11/01/17
Earnings Per Share ttm 3.23
EPS Growth vs. Prev Qtr 10.13%
EPS Growth vs. Prev Year 10.13%
Annual Dividend Rate, $ 0.60
Annual Dividend Yield 0.81%
Most Recent Dividend 0.15 on 08/18/17
Next Ex-Dividends Date 08/18/17
Dividend Payable Date 08/31/17
Dividend Payout Ratio 4.56
Most Recent Split 2-1 on 03/10/14

CTSH Ratios

Ratio
Price/Earnings ttm 23.03
Price/Earnings forward 22.47
Price/Earnings to Growth 1.70
Return on Equity % 14.48
Return on Assets % 13.98
Profit Margin % 11.51
Debt/Equity 0.07
Price/Sales 3.26
Price/Cash Flow 20.61
Price/Book 4.19
Book Value/Share 17.77
Interest Coverage 106.83

CTSH Dividends

Date Value
08/18/17 $0.1500
05/18/17 $0.1500
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart